Organoids are three-dimensional (3D) miniaturized and self-organizing tissue structures grown from stem cells that mimic key structural and functional features of real organs. They reproduce complex cellular interactions, architecture and biological behavior, making them more physiologically relevant than traditional 2D cell cultures. The primary purpose of organoids is to provide realistic biological models for disease research, drug discovery, toxicology testing and personalized medicine.
The organoids market consists of sales, by entities (organizations, sole traders, or partnerships), of organoids products that are miniaturized and simplified three-dimensional versions of organs produced in vitro. These structures are derived from stem cells or tissue cells and exhibit realistic microanatomy with self-renewal and differentiation capacities.
The global organoids market reached a value of nearly $690.06 million in 2024, having grown at a compound annual growth rate (CAGR) of 21.03% since 2019. The market is expected to grow from $690.06 million in 2024 to $1,605.46 million in 2029 at a rate of 18.40%. The market is then expected to grow at a CAGR of 17.71% from 2029 and reach $3,627.43 million in 2034.
Rise In Investments In Pharmaceutical And Biotechnology Companies
A Rise in investments in pharmaceutical and biotechnology companies contributed to the growth of the organoids market in the historic period. As funding surged within the biotech sector, organizations were able to allocate greater financial resources toward innovative platforms such as organoids, recognizing their potential to streamline drug development and reduce costly failures. Enhanced capital availability encouraged companies to expand laboratory capacities, acquire specialized stem cell technologies, and develop sophisticated organoid-based models for screening and validation. For instance, in September 2025, according to the Fierce Biotech, a US-based information services company, reported that the National Institutes of Health (NIH) is advancing its goal of minimizing animal use in drug testing by awarding $87 million in contracts to establish the Standardized Organoid Modeling (SOM) Cente. Therefore, Rise in investments in pharmaceutical and biotechnology companies drove the growth of the organoids market.
Focus On Vascularized And Functionally Mature Organoid Models
Companies operating in the organoids market are focusing on vascularized and functionally mature organoid models that better replicate human tissue architecture and physiological responses, enabling advancements in disease modeling, regenerative therapies, and drug testing applications. For instance, in June 2025, Cincinnati Children's Hospital Medical Center, a US-based hospital, engineered a liver organoid capable of forming its own organ-specific blood vessels, marking a significant advancement in tissue engineering. Using a multilayer gel technique, liver sinusoidal progenitor cells were guided to migrate, sprout, and integrate with surrounding liver cells to form functional sinusoid-like vasculature. These vascularized organoids also produced critical coagulation factors, including Factor VIII, and were able to correct bleeding in hemophilia-model mice. The approach helps overcome the long-standing limitation of organoids lacking internal vasculature, and may pave the way for transplantable liver tissue, enhanced disease models, and novel therapies for coagulation disorders.
The global organoids markets is concentrated, with large players operating in the market. The top 10 competitors in the market made up 33.53% of the total market in 2024.
Organoids Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global organoids market as it emerges from the COVID-19 shut down.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for organoids? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The organoids market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider organoids market; and compares it with other markets.
The report covers the following chapters
- Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by source, by applications and end-user.
- Key Trends: - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Growth Analysis And Strategic Analysis Framework: - Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Global Market Size And Growth: - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional And Country Analysis: - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
- Market Segmentation Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by product, by source, by application and end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
- Regional Market Size And Growth: - Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape: - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major And Innovative Companies: - Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking: - Briefs on the financials comparison between major players in the market.
- Competitive Dashboard: - Briefs on competitive dashboard of major players.
- Key Mergers And Acquisitions: - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Recent Developments: - Information on recent developments in the market covered in the report
- Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions And Recommendations- This section includes recommendations for organoids providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix: - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
- 1) By Product: Hepatic Organoid; Colorectal Organoid; Intestinal Organoid; Other Organoid
- 2) By Source: Pluripotent Stem Cells; Organ-Specific Adult Stem Cells
- 3) By Application: Developmental Biology; Disease Pathology Of Infectious Disease; Regenerative Medicine; Drug Toxicity And Efficacy Testing; Drug Discovery And Personalized Medicine; Other Applications
- 4) By End-User: Hospitals And Diagnostic Centers; Biotechnology And Pharmaceutical Companies; Other End-Users
- Companies Mentioned: Thermo Fisher Scientific Inc.; Corning Incorporated; Merck KGaA (Hubrecht Organoid Technology (HUB)); STEMCELL Technologies; Danaher Corporation (Cellesce Ltd)
- Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time-series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; organoids indicators comparison.
- Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes."